Published in BMC Neurol on July 15, 2013
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
The association between symptoms of mental disorders and health risk behaviours in Vietnamese HIV positive outpatients: a cross-sectional study. BMC Public Health (2017) 0.75
Prevalence of HIV Associated Neurocognitive Deficit among HIV Positive People in Ethiopia: A Cross Sectional Study at Ayder Referral Hospital. Ethiop J Health Sci (2017) 0.75
4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol} (TIMBD) suppresses HIV1-gp120 mediated production of IL6 and IL8 but not CCL5. Sci Rep (2017) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res (2004) 29.02
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol (2010) 1.87
Neurologic and psychiatric complications of antiretroviral agents. AIDS (2002) 1.70
HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS (2010) 1.56
HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol (2010) 1.31
Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav (2009) 1.29
Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med (2009) 1.22
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc (2010) 1.20
The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- a preliminary report. Afr J Psychiatry (Johannesbg) (2008) 1.17
HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS Behav (2011) 1.12
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci (2009) 1.07
The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon. J Acquir Immune Defic Syndr (2008) 1.06
NeuroAIDS in Africa. J Neurovirol (2010) 1.05
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One (2012) 0.99
Performance in Luria's fist-edge-palm test according to educational level. Cogn Behav Neurol (2005) 0.93
Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. AIDS Patient Care STDS (2011) 0.88
High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients. Int J STD AIDS (2010) 0.86
Education effects on the International HIV Dementia Scale. J Neurovirol (2010) 0.85
Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: the challenge and need for culturally valid screening tests in South Africa. Clin Neuropsychol (2013) 0.81
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med (2009) 4.17
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med (2008) 2.65
Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.36
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med (2011) 2.31
Deployment and the use of mental health services among U.S. Army wives. N Engl J Med (2010) 2.21
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med (2005) 1.83
Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model. AIDS Behav (2010) 1.67
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med (2011) 1.66
Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med (2013) 1.64
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61
A comparison of the wellbeing of orphans and abandoned children ages 6-12 in institutional and community-based care settings in 5 less wealthy nations. PLoS One (2009) 1.56
Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J Clin Microbiol (2010) 1.52
HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care (2013) 1.45
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med (2009) 1.41
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry (2009) 1.38
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med (2011) 1.38
European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership. BMC Public Health (2009) 1.35
HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol (2010) 1.31
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Saf (2008) 1.20
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS (2012) 1.18
Insomnia in patients with depression: a STAR*D report. CNS Spectr (2010) 1.18
Early warning indicators for HIV drug resistance in Cameroon during the year 2010. PLoS One (2012) 1.16
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry (2010) 1.13
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry (2011) 1.12
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr (2005) 1.09
Diagnostic accuracy of Spanish language depression-screening instruments. Ann Fam Med (2009) 1.09
Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS (2012) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Prevalence and predictors of HIV-related stigma among institutional- and community-based caregivers of orphans and vulnerable children living in five less-wealthy countries. BMC Public Health (2010) 1.08
Knowledge of Pregnant Women on Mother-to-Child Transmission of HIV in Yaoundé. Open AIDS J (2011) 1.07
The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep (2012) 1.06
Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care (2007) 1.06
Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry (2004) 1.01
The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Saf (2009) 1.00
Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genet Med (2006) 1.00
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract (2007) 0.99
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One (2012) 0.99
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol (2005) 0.97
Physical activity and depressive symptoms among pregnant women: the PIN3 study. Arch Womens Ment Health (2010) 0.95
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings. BMC Public Health (2013) 0.94
Depressive symptoms among working women in rural North Carolina: a comparison of women in poultry processing and other low-wage jobs. Int J Law Psychiatry (2007) 0.93
The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med (2010) 0.92
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS (2013) 0.92
Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety (2012) 0.92
Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. J Clin Psychiatry (2007) 0.91
Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry (2010) 0.91
Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics (2008) 0.90
Impact of malaria on hematological parameters in people living with HIV/AIDS attending the Laquintinie Hospital in Douala, Cameroon. PLoS One (2012) 0.90
Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol (2008) 0.90
Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci (2009) 0.89
Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health (2013) 0.89
Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatr Serv (2010) 0.89
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS (2015) 0.89
Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiol Drug Saf (2010) 0.89
Some social determinants of urinary schistosomiasis in Northern Cameroon: implications for schistosomiasis control. Afr J Health Sci (2007) 0.88
Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care (2014) 0.88
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry (2007) 0.88
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv (2011) 0.88
An update of malaria infection and anaemia in adults in Buea, Cameroon. BMC Res Notes (2010) 0.87
Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatr Serv (2012) 0.87
Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid. Open AIDS J (2009) 0.86
Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003) (2009) 0.86
Evaluation of the Menopause-Specific Quality of Life Questionnaire: a factor-analytic approach. Menopause (2012) 0.86
Accuracy of standard measures of family planning service quality: findings from the simulated client method. Stud Fam Plann (2014) 0.86
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract (2008) 0.86
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav (2014) 0.86
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev (2012) 0.85
Hematuria and dysuria in the self-diagnosis of urinary schistosomiasis among school-children in Northern Cameroon. Afr J Health Sci (2007) 0.85
In-home mental health treatment for individuals with HIV. AIDS Patient Care STDS (2012) 0.85
Yellow fever control in Cameroon: where are we now and where are we going? BMC Med (2008) 0.84
Predicting fatigue and depression in HIV-positive gay men. Psychosomatics (2002) 0.84
Sexual behavior of HIV-positive women in Cameroon. J Int Assoc Provid AIDS Care (2011) 0.84
Quality of Care and Contraceptive Use in Urban Kenya. Int Perspect Sex Reprod Health (2015) 0.84
Ranking antidepressants. Lancet (2009) 0.84
Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv (2010) 0.83
Knowledge, attitudes, and practice of Cameroonian medical students and graduating physicians with respect to epilepsy. Epilepsia (2009) 0.82